FDA Inspection 1195155 — Tennessee Blood Services Corp
The FDA completed an inspection of Tennessee Blood Services Corp on January 12, 2023 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 12, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Memphis, TN (United States)